The chart is not accessible to screen readers. Please switch to the table view to access the data.
Advertisement
Advertisement
Percentage of patients for which a certain drug is ineffective, by therapy class
Share of patients for which a certain drug is ineffective by therapy class
This statistic displays the percentage of patients for which a certain drug is ineffective, by therapy class. As to a study in 2001, for 40 percent of asthma patients a particular drug in this therapy class was ineffective.
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
Professional Account
For teams of up to 99 users
Talk to sales for pricing
- Free + Premium Statistics
- Reports
- Market ÌÇÐÄÆƽâ°æ
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Other statistics that may interest you Personalized medicine
Premises
7
- Basic Statistic Patients without improvement after taking selected top selling drugs 2015
- Basic Statistic Share of patients for which a certain drug is ineffective by therapy class
- Basic Statistic Technological advances in the genome sequencing area 2003-2020
- Basic Statistic Technological advances in genomic medicine 2003-2020
- Basic Statistic Number of discovered genes with known disease-causing mutations 2003 and 2015
- Basic Statistic Patients whose tumors are driven by genetic mutations by cancer type 2016
- Basic Statistic Incidence of biomarker positivity cancer patients 2017 U.S. by type
Biomarkers
6
- Premium Statistic U.S. development phase success rates for drugs with and without biomarkers 2011-2020
- Basic Statistic Total market size for biomarkers in the United States 2015-2024
- Basic Statistic Market size for biomarkers in the United States by disease 2015-2024
- Premium Statistic Market size for cancer biomarkers in the United States by application 2015-2024
- Basic Statistic Biomarker technologies: global market forecast 2024 and 2029
- Basic Statistic Top sequencing companies worldwide by revenue 2017
PM key data
5
- Basic Statistic Personalized medicine - investment growth 2006-2015
- Premium Statistic Number of personalized medicines in the U.S. 2008-2020
- Basic Statistic Personalized medicine in development by type 2015
- Basic Statistic Personalized medicines as percent of new molecular entities 2014-2024
- Basic Statistic Total global market for personalized medicine 2022-2032
Views on PM
6
- Basic Statistic Healthcare professionals about their organization's focus 2016 vs. 2021
- Basic Statistic Healthcare organizations personalized medicine primary focus 2016 vs. 2018
- Basic Statistic U.S. adults that have not heard of personalized medicine 2018
- Basic Statistic Reactions among U.S. adults to description of personalized medicine 2018
- Basic Statistic U.S. opinions on insurance coverage of personalized tests and treatments in 2018
- Basic Statistic Major concerns among adults regarding personalized medicine in the U.S. in 2018
Outlook
4
- Basic Statistic Global market for personalized medicine by product 2015-2022
- Premium Statistic Size of global DNA sequencing market in 2023 and 2029
- Basic Statistic Size of global companion diagnostics market 2014-2024
- Basic Statistic Global next generation sequencing market share forecast by technology 2024
Further Content: You might find this interesting as well
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
Professional Account
For teams of up to 99 users
Talk to sales for pricing
- Free + Premium Statistics
- Reports
- Market ÌÇÐÄÆƽâ°æ
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Personalized Medicine Coalition. (November 17, 2020). Percentage of patients for which a certain drug is ineffective, by therapy class [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 25, 2026, from /statistics/726812/patients-for-which-a-certain-drug-is-ineffective-by-therapy-class/
Personalized Medicine Coalition. "Percentage of patients for which a certain drug is ineffective, by therapy class." Chart. November 17, 2020. ÌÇÐÄÆƽâ°æ. Accessed July 25, 2026. /statistics/726812/patients-for-which-a-certain-drug-is-ineffective-by-therapy-class/
Personalized Medicine Coalition. (2020). Percentage of patients for which a certain drug is ineffective, by therapy class. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 25, 2026. /statistics/726812/patients-for-which-a-certain-drug-is-ineffective-by-therapy-class/
Personalized Medicine Coalition. "Percentage of Patients for Which a Certain Drug Is Ineffective, by Therapy Class." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 17 Nov 2020, /statistics/726812/patients-for-which-a-certain-drug-is-ineffective-by-therapy-class/
Personalized Medicine Coalition, Percentage of patients for which a certain drug is ineffective, by therapy class ÌÇÐÄÆƽâ°æ, /statistics/726812/patients-for-which-a-certain-drug-is-ineffective-by-therapy-class/ (last visited July 25, 2026)
Percentage of patients for which a certain drug is ineffective, by therapy class [Graph], Personalized Medicine Coalition, November 17, 2020. [Online]. Available: /statistics/726812/patients-for-which-a-certain-drug-is-ineffective-by-therapy-class/
Advertisement